Quick answer
Do not choose this comparison from a feature grid alone. For using a short trial to make an evidence-based buying decision, the useful question is whether the product shortens work you already verify. Vithoulkas Compass is a web-based expert system built around a curated Kent-derived repertory, case analysis, remedy differentiation, and the Vithoulkas method. Homeo AI is a focused clinical copilot for note-to-rubric-to-differential work. Both need a known-case trial before identifiable patient data or live prescribing work enters the system.
What should a practitioner test before familiarity and sunk cost influence the purchase? The evaluation unit is one completed workflow. For using a short trial to make an evidence-based buying decision, an attractive screen or quick answer is only an intermediate observation. The result must remain correctable and useful when the practitioner returns days or weeks later.
What Vithoulkas Compass offers
The competitor facts below were checked against Vithoulkas Compass overview and About the Vithoulkas Compass expert system on 2026-07-22. They describe the public product, not an independent clinical validation.
- Vithoulkas Compass describes itself as an online expert system for classical homeopathy.
- Its repertory is based on Kent and is curated for consistency rather than maximum source volume.
- The platform says its mathematical engine was developed from case analysis and the prescribing method of George Vithoulkas.
- Its current workflow includes remedy analysis, differentiation, and Synapse-assisted questioning and rubric selection.
Vithoulkas Compass's public positioning is clear enough to form a test, but not enough to make a purchase. Product pages describe the designed experience. A trial shows the correction burden, source boundary, and record quality that a practitioner will actually live with.
What this comparison is really testing
A trial should answer a small set of operational questions. Browsing features without running known cases produces confidence but little evidence.
One pair-specific checkpoint is worth writing down before the trial: The web interface avoids a local software installation. The corresponding risk is this: Its workflow should be compared with the clinic's needs for free-form notes, records, and follow-up documentation. A useful test must be able to prove or disprove both statements with the same case.
Where Vithoulkas Compass may fit better
- The system has a clear classical method instead of trying to cover every possible school.
- A curated repertory can make the reasoning surface more controlled.
- The web interface avoids a local software installation.
- Differentiation tools support the step after repertorisation, where many cases remain uncertain.
These are real reasons to choose Vithoulkas Compass. A clinic that already works comfortably inside its method, library, or general productivity ecosystem may gain little from replacing that part of the workflow. Homeo AI can also be used beside another repertory or research tool when the main need is note structuring and follow-up continuity.
Where the fit needs closer testing
- Practitioners who rely on other repertories or methods need to test that fit carefully.
- The platform's method-specific strength can also be a constraint for mixed-method practices.
- A statistical or expert score still needs confirmation against the complete patient context.
- Its workflow should be compared with the clinic's needs for free-form notes, records, and follow-up documentation.
None of these points proves that Vithoulkas Compass is unsuitable. They identify the parts of the purchase that a homepage cannot settle. Ask the vendor, read the current terms, and test the exact edition or account you plan to use.
How Homeo AI approaches the same job
Homeo AI is method-flexible and note-first. It focuses on structuring the patient's narrative, exposing rubric mappings, comparing sources, and keeping later visits tied to the baseline case. In practical terms, Homeo AI should save time between the consultation and the reviewable record. Test that whole interval, including corrections, rather than timing only the first response.
The most revealing action in this comparison is: Select three completed cases. Record what the product shows before and after that action. A genuine evidence trail should change in a way the practitioner can understand.
A practical head-to-head test
Use completed, de-identified cases whose reasoning and outcomes you already understand. Run the same material through both products without rewriting it to suit either interface.
- Select three completed cases
- Define pass or fail criteria
- Record time and corrections
- Export results before the trial ends
Write down time spent, material corrections, source gaps, and export quality. Repeat the test with a different case type and a second reviewer. This matters because familiarity with one interface can look like product quality during the first session.
Decision for a practitioner
For a buyer focused on using a short trial to make an evidence-based buying decision, the winner is the product with fewer material corrections and a clearer evidence trail. Price matters after that threshold is met. A cheap result that cannot be verified costs more during every future case.
Price and product features can change, so confirm them on the official sources linked below. Use completed, de-identified cases until your clinic has approved privacy, access, retention, and consent procedures. Neither product should make an emergency-care decision or replace the practitioner's responsibility for diagnosis, referral, prescription, potency, dosage, and follow-up.
Official sources checked
Product facts reviewed 2026-07-22. Confirm current features, prices, source libraries, and terms with the vendor.